Is Bristol Myers Squibb Stock A Better Pick Over Its Industry Peer?
- Wednesday, March 22, 2023, 7:14
- Market
- Add a comment
Investors have assigned a higher multiple to LLY stock due to its robust pipeline and better profitability, as discussed below If we look at stock returns, Eli Lilly, with 15% returns in the last twelve months, has fared better than BMS, down 5%, and the broader S&P 500 index, down 11%.
About the Author
admin123 has written 23519 stories on this site.
